1. Home
  2. DENN vs LRMR Comparison

DENN vs LRMR Comparison

Compare DENN & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DENN
  • LRMR
  • Stock Information
  • Founded
  • DENN 1953
  • LRMR N/A
  • Country
  • DENN United States
  • LRMR United States
  • Employees
  • DENN N/A
  • LRMR N/A
  • Industry
  • DENN Restaurants
  • LRMR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DENN Consumer Discretionary
  • LRMR Health Care
  • Exchange
  • DENN Nasdaq
  • LRMR Nasdaq
  • Market Cap
  • DENN 203.4M
  • LRMR 204.9M
  • IPO Year
  • DENN 1989
  • LRMR N/A
  • Fundamental
  • Price
  • DENN $3.95
  • LRMR $3.21
  • Analyst Decision
  • DENN Strong Buy
  • LRMR Strong Buy
  • Analyst Count
  • DENN 6
  • LRMR 7
  • Target Price
  • DENN $7.46
  • LRMR $17.86
  • AVG Volume (30 Days)
  • DENN 611.8K
  • LRMR 1.1M
  • Earning Date
  • DENN 08-04-2025
  • LRMR 08-06-2025
  • Dividend Yield
  • DENN N/A
  • LRMR N/A
  • EPS Growth
  • DENN N/A
  • LRMR N/A
  • EPS
  • DENN 0.33
  • LRMR N/A
  • Revenue
  • DENN $453,997,000.00
  • LRMR N/A
  • Revenue This Year
  • DENN $7.51
  • LRMR N/A
  • Revenue Next Year
  • DENN $1.98
  • LRMR N/A
  • P/E Ratio
  • DENN $12.01
  • LRMR N/A
  • Revenue Growth
  • DENN N/A
  • LRMR N/A
  • 52 Week Low
  • DENN $2.85
  • LRMR $1.61
  • 52 Week High
  • DENN $7.73
  • LRMR $10.25
  • Technical
  • Relative Strength Index (RSI)
  • DENN 44.45
  • LRMR 55.23
  • Support Level
  • DENN $3.80
  • LRMR $3.11
  • Resistance Level
  • DENN $4.48
  • LRMR $3.40
  • Average True Range (ATR)
  • DENN 0.20
  • LRMR 0.24
  • MACD
  • DENN -0.05
  • LRMR -0.03
  • Stochastic Oscillator
  • DENN 20.88
  • LRMR 45.98

About DENN Denny's Corporation

Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: